CRISPR-based Phage Therapy Shines in the First Human Trial June 1, 2023 SNIPR Biome, a Danish microbiome technology company, has unveiled promising results from the initial phase of their groundbreaking CRISPR-based phage therapy targeting Escherichia coli…
Revolutionizing Infection Treatment: SNIPR Biome’s CRISPR-armed Phage Therapy Targets Antibiotic-Resistant E. Coli in Gut May 13, 2023 SNIPR Biome ApS has made a groundbreaking discovery in the field of microbiology, paving the way for a new era of microbial gene therapy….
